2023
Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis
HRADILEK, Pavel, Kamila Zondra REVENDOVA ZONDRA, Jana HORAKOVA, Radovan BUNGANIC, Ondřej PELÍŠEK et. al.Základní údaje
Originální název
Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis
Autoři
HRADILEK, Pavel (203 Česká republika, garant), Kamila Zondra REVENDOVA ZONDRA (203 Česká republika), Jana HORAKOVA (203 Česká republika), Radovan BUNGANIC (203 Česká republika), Ondřej PELÍŠEK (203 Česká republika, domácí), David ZEMAN (203 Česká republika), Pavla HANZLIKOVA (203 Česká republika) a Pavlina KUSNIEROVA (203 Česká republika)
Vydání
Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2023, 1213-8118
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 0.900 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130656
Organizační jednotka
Lékařská fakulta
UT WoS
000922647200001
Klíčová slova anglicky
multiple sclerosis; biomarkers; neurofilament light chain; CXCL13; clinical course
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 30. 1. 2024 08:12, Mgr. Tereza Miškechová
Anotace
V originále
Aim. The aim of this study was to identify whether NfL and CXCL13 cerebrospinal fluid (CSF) concentrations at diagnos-tic lumbar puncture can predict the course of multiple sclerosis (MS) in terms of relapses, higher expanded disability status scale (EDSS) and magnetic resonance imaging (MRI) activity.Methods. We conducted a single-centre prospective observational cohort study at the MS center, University Hospital Ostrava, Czech Republic. CSF NfL (cNfL) and CXCL13 concentrations were examined (ELISA method) in patients with clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) at the time of diagnostic lumbar puncture.Results. A total of 44 patients with CIS or early RRMS were enrolled, 31 (70.5%) of whom were women. The median age at the time of CSF sampling was 31.21 years (IQR 25.43-39.32), and the follow-up period was 54.6 months (IQR 44.03 - 59.48). In the simple and multiple logistic regression models, CXCL13 levels did not predict relapses, MRI activ-ity or EDSS > 2.5. Similarly, cNfL concentrations did not predict relapses or MRI activity in either model. In the multiple regression, higher cNfL levels were associated with reaching EDSS > 2.5 (odds ratio [OR] 1.002, 95% confidence interval [CI] 1.000 to 1.003).Conclusions. Our data did not confirm cNfL and/or CXCL13 CSF levels were predictive factors for disease activity such as relapses and MRI activity at the time of diagnostic lumbar puncture in patients with RRMS. While cNfL CSF levels predicted higher disability only after adjustment for other known risk factors, elevated CSF CXCL13 did not predict higher disability at all.